Clinical trial
Preventing Recurrent Ulcer Bleeding in Arthritis Patients Using Esomeprazole…
NCT00365313 · Chinese University of Hong Kong, Other · Completed
Key facts
| NCT number | NCT00365313 |
|---|---|
| Title | Preventing Recurrent Ulcer Bleeding in Arthritis Patients Using Esomeprazole Plus Celecoxib |
| Official title | A Phase 3 Double Blinded, Randomized, Placebo Controlled Trial of Proton Pump Inhibitor for the Prevention of Recurrent Ulcer Bleeding in Patients Receiving a COX-2 Inhibitor |
| Lead sponsor | Chinese University of Hong Kong, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Arthritis, Bleeding Ulcer |
| Intervention type | Drug |
| Interventions | celecoxib, esomeprazole |
| Enrollment | 273 |
| Start date | Aug 1, 2002 |
| Completion | Jun 1, 2005 |
| First posted | Aug 17, 2006 |
| Last update posted | Oct 27, 2006 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: